AC
SURF

Aaron Cowen’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Aaron Cowen’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-476,879
Closed -$3.13M – 117
2020
Q2 		$3.13M Buy
+476,879
New +$1.72M 0.07% 61

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aaron Cowen's SURF Position: Q3 2020 in Review

Aaron Cowen sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2020, closing a stake of 476,879 shares — an estimated $3.13M sold.

Aaron Cowen first reported a position in SURF in Q2 2020 and held it in 1 quarter. The position peaked at $3.13M in Q2 2020. 59 funds tracked by Wall St. Rank hold SURF as of Q3 2020.

  • Aaron Cowen reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Aaron Cowen sold 476,879 Surface Oncology, Inc. Common Stock shares in Q3 2020, an estimated $3.13M.
  • Aaron Cowen first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Aaron Cowen's Surface Oncology, Inc. Common Stock position peaked at $3.13M in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2020.

Based on Suvretta Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.